<DOC>
	<DOCNO>NCT01675596</DOCNO>
	<brief_summary>The objective study observe safety , efficacy cost effectiveness Edwards SAPIEN XT valve treatment severe calcific degenerative aortic stenosis .</brief_summary>
	<brief_title>The SOLACE-AU Clinical Trial</brief_title>
	<detailed_description>This multi-centre , prospective , consecutively enrol , non-randomized clinical trial . The comparatator group consist subject undergo surgical aortic valve replacement Cohort A PARTNER II Trial .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Age &gt; 70 year STS Score &gt; 4 Heart team agree eligibility include assessment TAVR AVR appropriate Age &lt; 70 year Evidence acute myocardial infarction â‰¤ 30 day Aortic valve congenital unicuspid congenital bicuspid valve , noncalcified Stroke transient ischemic attack ( TIA ) within 6 month procedure</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Aortic Stenosis</keyword>
	<keyword>Transfemoral</keyword>
	<keyword>Transcatheter Heart Valve</keyword>
</DOC>